ANMI PSMA kit VEAT notice
A Voluntary Ex-Ante Transparency (VEAT) Notice
by THE ROYAL MARSDEN NHS FOUNDATION TRUST
- Source
- Find a Tender
- Type
- Contract (Supply)
- Duration
- not specified
- Value
- £700K
- Sector
- HEALTH
- Published
- 16 May 2022
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
Royal Marsden Hospital
2 buyers
- Royal Marsden NHS Trust London
1 supplier
- Xiel Shepton Mallet
Description
.The Royal Marsden Hospital requires purchase of ANMI PSMA Setrile 360 VIALS and ANMI Elution Tools Gen A to treat prostate cancer. ANMI PSMA Setrile 360 Vials and ANMI Elution Tools Gen A is the only viable kit for imaging of prostate cancer, disease progression or staging of cancer in UK. There is no licensed product in the UK at the moment, XIEL is the only official UK Distributor of the ANMI HBEDCC-11 PSMA Kit and follows the Regulated Import Pathway approved by the MHRA for this product.
Total Quantity or Scope
.Direct Award procedure to another supplier. The Royal Marsden Hospital requires purchase of ANMI PSMA Setrile 360 VIALS and ANMI Elution Tools Gen A to treat prostate cancer. ANMI PSMA Setrile 360 Vials and ANMI Elution Tools Gen A is the only viable kit for imaging of prostate cancer, disease progression or staging of cancer in UK.
Award Detail
1 | Xiel (Shepton Mallet)
|
CPV Codes
- 33100000 - Medical equipments
Indicators
- Award on basis of price and quality.
Legal Justification
There is no licensed product in the UK at the moment, XIEL is the only official UK Distributor of the ANMI HBEDCC-11 PSMA Kit and follows the Regulated Import Pathway approved by the MHRA for this product.
Reference
- FTS 012588-2022